Efficacy and Tolerability of Ambroxol Lozenge 20 mf in Relieving Pain of Sore Throat in Pat. With Acute/Viralpharyngitis

PHASE3CompletedINTERVENTIONAL
Enrollment

751

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

June 30, 2006

Study Completion Date

June 30, 2006

Conditions
Pharyngitis
Interventions
DRUG

Ambroxol hydrochloride (Mucoangin?)

DRUG

benzocaine

Trial Locations (14)

61002

Regional Student Hospital, Kharkiv

61022

Regional Clinical Hospital, Kharkiv

61024

City Clinical Otolaryngological Hospital, Kharkiv

61037

City Clinical Hospital No. 17, Kharkiv

61050

City Clinical Hospital No. 11, Kharkiv

61072

City Clinical Hospital No. 26, Kharkiv

65006

City Clinical Hospital No. 11, Odesa

69600

Regional Clinical Hospital, Zaporizhzhya

010224

Medicover, Bucharest

010626

Medicover, Bucharest

021106

Medicover, Bucharest

030303

Victor Babes Clincial Hospital, Bucharest

03057

Academy of Medical Science named after O.S. Kolomyichenko, Kiev

04112

City Clinical Hospital No. 9, Kiev

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY